Related Experiment Videos
[Progress in the studies of vasoactive intestinal polypeptide].
1Department of Urology, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, China. shenzj@mail.hz.zj.cn
Zhonghua Nan Ke Xue = National Journal of Andrology
|August 5, 2005
Summary
Vasoactive intestinal polypeptide (VIP) effectively relaxes smooth muscles and acts as a neurotransmitter for penile erection. VIP-based therapies show promise for treating erectile dysfunction.
Area of Science:
- Endocrinology
- Neuroscience
- Urology
Context:
- Vasoactive intestinal polypeptide (VIP) is recognized for its vasodilatory and smooth muscle relaxant properties.
- VIP plays a role in the physiological mechanisms of penile erection, meeting several neurotransmitter criteria.
Purpose:
- To explore the potential of Vasoactive intestinal polypeptide (VIP) as a therapeutic agent for erectile dysfunction.
- To evaluate VIP donor strategies and gene transfer as treatment modalities.
Summary:
- Vasoactive intestinal polypeptide (VIP) exhibits potent vasodilatory and smooth muscle relaxant effects.
- Its role as a neurotransmitter in mediating penile erection is well-established.
- VIP donor administration and gene therapy represent promising physiological approaches for erectile dysfunction treatment.
Impact:
- This research highlights novel therapeutic avenues for erectile dysfunction.
- It underscores the physiological relevance of VIP in sexual function and its potential clinical applications.